Recent News

• Meet selectION, Inc. at the 44^th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 12^th-15^th, 2026 December 12, 2025
• selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease October 21, 2025
• Congratulations to our Scientific Advisor, Dr. Fred Ramsdell, for receiving the 2025 Nobel Prize in Physiology. October 6, 2025
• Meet selectION, Inc. at BIO International Convention in Boston,MA, on June 16^th-19^th, 2025 May 26, 2025
• Meet selectION, Inc. at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 13^th-16^th, 2025 December 11, 2024